With a significant increase in HAIs in 2020, combined with the pressures of the COVID19 pandemic, NP staff shortages and ever-increasing turnover, the need for high-performing infection prevention and control (IPandC) programs has never was so obvious.
Resilient IPC programs to protect patients, visitors and healthcare professionals, to comply with mandatory public reporting, to address multi-drug resistant organisms (MDRO), to promote antimicrobial stewardship (AMS) efforts and to improve quality and financial results.
In this live industry APIC webinar, Mackenzie Weise, MPH, CIC, Clinical Infection Prevention Program Manager, discusses the following: Common challenges faced by infection prevention teams Key features of a clinical infection prevention program Infection Prevention and Control Elements Necessary to Successfully Implement and Sustain a High Performance IPandC Program